ISELIN, New Jersey, August 20, 2012 /PRNewswire/ --
Indegene Inc. (http://www.indegene.com), a leading global pharmaceutical and healthcare solutions provider, today announced the launch of TrialPedia 2.0 with Advantage Insights for clinical trial analytics and decision support.
The number of drugs approved by the USFDA over the years has been declining, and is testament to the difficulties pharmaceutical companies continue to face to drive revenues. As companies grapple with shrinking pipelines, stricter safety and regulatory requirements, and spiraling costs to bring products to the marketplace, the need for clinical trial analytics is paramount.
TrialPedia 2.0, a proprietary platform offered by Indegene, helps Clinical Development and Operations, R&D, Competitive Intelligence (CI), BD & Licensing, as well as Strategic Marketing professionals effectively analyze clinical literature and trial data seamlessly, and benchmark competitive Clinical Development Programs (CDPs) across the industry. TrialPedia provides quick and comprehensive answers to strategic clinical development and marketing questions including market evolution, competitive label claims, licensing options, and future sales projections. It includes industry leading features such as therapy area specific query parameters, claim space prediction tools, trial feasibility, operations analysis, and identification of competitive differentiators. TrialPedia 2.0 combines over 300 man-years of effort in assimilating knowledge to build a comprehensive solution.
Clients can further enhance the value of TrialPedia via Advantage Insights - a service bureau that is designed to enhance the business value of clinical trial analytics and help clients comprehensively research, study, monitor, report, and derive insights from the global clinical trial landscape. In this model, Indegene leverages TrialPedia and its expertise to perform analysis and reporting on behalf of the client. Clients can also avail of custom research and analysis through bundled Analyst Hours Support.
Manish Gupta, CEO - Indegene said "With Advantage Insights, in addition to clients gaining access to TrialPedia 2.0, they can leverage our deep research and analytics expertise for all their reporting and analysis needs. We believe that this will enable clients to navigate the business environment more effectively and with greater responsiveness."
Indegene is a leading provider of R&D, commercial and marketing solutions to global pharmaceutical and healthcare organizations. We partner with clients to drive both productivity and revenues by delivering better patient outcomes, optimizing cost, enhancing R&D agility, and improving sales and marketing effectiveness. We apply deep scientific knowledge, flexible delivery models, proprietary technology, and a client-centric approach to drive transformational initiatives. To learn more about Indegene, visit us at http://www.indegene.com.
For further information contact:
US and Europe
Ann Marie Craggan
|SOURCE Indegene Lifesystems Pvt Ltd|
Copyright©2012 PR Newswire.
All rights reserved